News from ABBVIE A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 18, 2014, 11:00 ET

AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards

  AbbVie today announced the 40 outstanding students with cystic fibrosis (CF) who will each receive $2,500 to pursue their undergraduate or...

Aug 04, 2014, 08:00 ET

AbbVie Receives EMA and FDA Orphan Drug Designation for Investigational Compound ABT-414 in the Treatment of Glioblastoma Multiforme

AbbVie (NYSE:ABBV) today announced the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted orphan drug...

Aug 01, 2014, 10:00 ET

AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program

 AbbVie (NYSE: ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced a partnership to expand awareness of proper nutritional...

Jul 25, 2014, 07:47 ET

AbbVie Reports Second-Quarter 2014 Financial Results

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...

Jul 23, 2014, 12:44 ET

AbbVie to Host Second-Quarter Earnings Conference Call

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...

Jul 18, 2014, 06:17 ET
Jul 18, 2014, 06:14 ET
Jul 18, 2014, 06:12 ET
Jul 18, 2014, 06:10 ET
Jul 16, 2014, 10:00 ET

AbbVie Announces Inaugural Week of Possibilities Volunteer Program to Support Six Schools in North Chicago, Ill., and Worcester, Mass.

AbbVie today announced its first Week of Possibilities, an employee volunteer program to support educational improvement projects in local...

Jul 08, 2014, 07:50 ET
Jun 26, 2014, 08:00 ET

AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) in Patients with Advanced Breast Cancer

AbbVie (NYSE: ABBV) today announced the initiation of a Phase III clinical trial evaluating the safety and efficacy of its investigational...

Jun 25, 2014, 08:45 ET
Jun 25, 2014, 07:05 ET
Jun 25, 2014, 07:00 ET
Jun 23, 2014, 07:45 ET
Jun 19, 2014, 23:48 ET
Jun 19, 2014, 11:28 ET

AbbVie Declares Quarterly Dividend

 The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.42 per share.  The cash dividend is payable...

Jun 17, 2014, 02:00 ET

European Medicines Agency Validates Marketing Authorization Applications for AbbVie's Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C

AbbVie (NYSE: ABBV) announced today that the Marketing Authorization Applications (MAAs) for its investigational, all-oral, interferon-free regimen...